【Pharmaceutical Network Technical Articles】In recent years, with the continuous introduction of national policies to support pharmaceutical innovation, the number of innovative drugs developed by domestic pharmaceutical companies has also begun to rise. Some data show that from 2008-2018, 41 new class 1 drugs were approved and listed in China, of which 10 were all approved in 2018; in 2019, 12 domestic class 1 innovative drugs were approved and listed. And this year, just in the past month, more than four applications for listing new Class 1 drugs have been accepted.
　　From the above point of view, with the enhancement of China's independent medical technology, under the impetus of policy and market, innovation has gradually become the source power and direction of the development of domestic pharmaceutical companies, by which the development of innovative drugs has also begun to usher in the golden age. However, it is worth noting that some industry insiders believe that, although the domestic innovative drug industry is developing in full swing, but to realize the leap from generic to innovation is still a long and painful process, will also face many challenges.
　　For example, from the current point of view, the direction of pharmaceutical reform is mainly centered on the two major cores of “drug efficiency” and “drug price”, not only to promote pharmaceutical innovation and process upgrading, but also committed to bursting the drug price bubble and reduce health insurance spending. Therefore, in the pharmaceutical industry set off a wave of reform, industrial upgrading will be imperative. The face of the “crisis” has been on the road, pharmaceutical companies not only need to research and development of new drugs, innovative pharmaceutical processes, but also need to pay attention to the innovation and upgrading of pharmaceutical equipment.
　　After all, pharmaceutical equipment and pharmaceutical production is closely related to the level of its technology is related to the quality of drug production. Therefore, to enhance the level of pharmaceutical equipment is of great significance. In fact, after years of development, China's pharmaceutical equipment and the past situation compared to the new, although there are still shortcomings compared with foreign equipment, but in terms of quality has been widely recognized.
　　A pharmaceutical company's procurement staff has said that the company and an equipment supplier to reach cooperation, mainly because both sides can ensure the quality of drugs, services to the people as a prerequisite. It is reported that the equipment supplier in the development of drugs for the pharmaceutical enterprises at the same time will be its control inspection, and provide consumables to assist. And pharmaceutical enterprises with technical support, strong cooperation, to achieve a win-win situation.
　　In order to better meet the development needs of the pharmaceutical industry, some industry insiders say, improve product technology is the basis of the foundation, pharmaceutical equipment companies to quality as the basis, and constantly push the boundaries of innovation. At present, under the Internet trend, more and more pharmaceutical equipment companies have realized the importance of digitalization, but also is using digitalization to accelerate the transformation and innovation. If there are pharmaceutical equipment companies to build a digital factory as the goal, is multifaceted to enhance the level of control of the production process of pharmaceutical companies, reduce material inventory, transportation and other production costs, and the establishment of multi-sector manufacturing resource synergy system to achieve a reasonable allocation of production resources to achieve collaboration in the development of production plans, deployment of production materials, as well as batch production of materials and quality data traceability.
　　In addition, with the continuous development of intelligent technology, there are pharmaceutical equipment companies in recent years, began to vigorously build high-end biomedical robotics and equipment for intelligent manufacturing of new model projects. It is reported that it has been accepted by the intelligent manufacturing new model project located in Changsha Ningxiang. The project can realize the whole life cycle management of the product from the whole process of research and development, manufacturing, logistics, service, etc., in the creation of pharmaceutical equipment, intelligent manufacturing new model and intelligent manufacturing standards at the same time, but also to further promote China's pharmaceutical equipment enterprises to the new model of intelligent manufacturing transformation.
　　Of course, in addition to improving technology and ensuring quality, pharmaceutical equipment companies also need to be market-oriented in order to better meet the technical needs of customers under innovation. At present, in the pharmaceutical enterprises vigorously develop innovation, biological drug research and development is increasingly becoming a hot spot, but more than ordinary drugs, biological drug research and development, production requirements are more stringent, so the choice of pharmaceutical equipment is also more demanding.
　　It is reported that some companies to better meet the needs of pharmaceutical companies, to further broaden their product range, the introduction of customized biopharmaceutical equipment, and the formation of orders. At the same time, there are enterprises relying on its accumulated high level of cold work technology, polishing technology, engineering design and installation technology, research and development and production of a series of biological fermentation tanks, stainless steel tanks, laboratory reactors, electrically heated reactors and other products.
 
　　In general, as domestic pharmaceutical companies continue to increase investment in innovation and R & D, the future may continue to have many heavyweight domestic innovative drugs listed one after another. In this context, will further promote China's pharmaceutical equipment industry to accelerate the transformation and upgrading, towards the direction of high quality.
Article link: pharmaceutical network https://www.zyzhan.com/news/detail/79701.html